Auditory complications in childhood cancer survivors: A report from the childhood cancer survivor study

Pediatric Blood and Cancer

Volumn 57, Issue 1, 2011, Pages 126-134

  Whelan, Kimberly ^a   Stratton, Kayla ^b   Kawashima, Toana ^b   Leisenring, Wendy ^b   Hayashi, Susan ^c   Waterbor, John ^d   Blatt, Julie ^e   Sklar, Charles A ^f   Packer, Roger ^g   Mitby, Pauline ^h   Robison, Leslie L ⁱ   Mertens, Ann C ^j  

^a University of Alabama at Birmingham   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

ⁱ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Late effects of therapy; Radiation therapy

Indexed keywords

PLATINUM COMPLEX;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVOR; CHILDHOOD CANCER; FEMALE; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTERIOR FOSSA; PRIORITY JOURNAL; QUESTIONNAIRE; TEMPORAL LOBE; TINNITUS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEARING LOSS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PLATINUM COMPOUNDS; QUALITY OF LIFE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SIBLINGS; TIME FACTORS; YOUNG ADULT;

EID: 79955727039     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23025     Document Type: Article

References (41)

1. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the U.S. by race and ethnicity for the diagnostic period 1975-1999. Cancer 2008; 113: 2575-2596.
2. Hudson MM. Survivors of childhood cancer: Coming of age. Hematol Oncol Clin NA 2008; 22: 211-231.
3. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2008; 100: 1368-1379.
4. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
5. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 2003; 290: 1583-1592.
6. Lackner H, Benesch M, Schagerl S, et al. Prospective evaluation of late effects of childhood cancer therapy with a follow-up over 9 years. Eur J Pediatr 2000; 159: 750-758.
7. Jereczek-Fossa BA, Zarowski A, Milani F, et al. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003; 29: 417-430.
8. Li Y, Womer RB, Silber JH. Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer 2004; 40: 2445-2451.
9. Grewal S, Merchant T, Reymond R, et al. Auditory late effects of childhood cancer therapy: A report from the Children's Oncology Group. Pediatrics 2010; 125: e938-e950.
10. Stohr W, Langer T, Kremers A, et al. Cisplatin-induced ototoxicity in osteosarcoma patients: A report from the late effects surveillance system. Cancer Invest 2005; 23: 201-207.
11. Knight K, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 2005; 23: 8588-8596.
12. Coradini PP, Cigana L, Selistre SG, et al. Ototoxicity from cisplatin therapy in childhood cancer. J Pediatr Hematol Oncol 2007; 29: 355-360.
13. Jehanne M, Lumbrose-LeRouic L, Savignoni A, et al. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer 2009; 52: 637-643.
14. Stohr W, Langer T, Kremer A, et al. Hearing function in soft tissue sarcoma patients after treatment with carboplatin: A report from the late effects surveillance system. Oncol Rep 2004; 12: 767-771.
15. Bertolini P, Lassalle M, Guilaine M, et al. Platinum compound-related ototoxicity in children: Long term follow-up reveals continuous worsening of hearing loss. Pediatr Hematol Oncol 2004; 26: 649-655.
16. Lambert MP, Shields C, Meadows AT. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Pediatr Blood Cancer 2008; 50: 223-226.
17. Schell MJ, McHaney VA, Green AA, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 1990; 8: 179-180.
18. Walker DA, Pillow J, Waters KD, et al. Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. Med Pediatr Oncol 1989; 17: 48-52.
19. Kretschman CS, Warren MP, Lavally BL, et al. Ototoxicity of preradiation cisplatin for children with central nervous tumors. J Clin Oncol 1990; 8: 1191-1198.
20. Miettinen S, Laurikarnen E, Johansson R, et al. Radiotherapy enhanced ototoxicity of cisplatin in children. Acta Otolaryngol Suppl 1997; 529: 90-94.
21. Bhandare N, Antonelli PJ, Morris CG, et al. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007; 67: 469-479.
22. Merchant TE, Gould CJ, Xiong X, et al. Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 2004; 58: 1194-1207.
23. Packer RJ, Gurney JG, Punkyo JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: The Childhood Cancer Survivor Study. J Clin Oncol 2003; 21: 3255-3261.
24. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 2009; 27: 2308-2318.
25. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 2002; 38: 229-239.
26. Henderson TO, Whitton J, Stovall M, et al. Secondary sarcomas in childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2007; 99: 300-308.
27. Stovall M, Weathers R, Kasper C, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: Use in epidemiologic studies. Radiat Res 2006; 166: 141-157.
28. Rubin DB. Multiple imputation for nonrepsonse in surveys. New York: John Wiley & Sons, Inc; 1987.
29. Taylor JMG, Munoz A, Bass SM, et al. Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Stat Med 1990; 9: 505-514.
30. Breslow NE, Daj NE. Statistical methods in cancer research: The design and analysis of cohort studies. New York, New York: Oxford University Press; 1994.
31. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
32. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695-706.
33. Oh Y, Kim C, Choi J, et al. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 2004; 72: 79-82.
34. Laverdiere C, Cheung NV, Kushner BH, et al. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer 2005; 45: 324-332.
35. Zuur CL, Simis YJ, Lansdaal PE, et al. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head and neck cancers: A multi-variate analysis. Int J Radiat Oncol Biol Phys 2007; 68: 1320-1325.
36. Kushner BH, Budnick A, Kramer K, et al. Ototoxicity from high dose use of platinum compounds in patients with neuroblastoma. Cancer 2006; 107: 417-422.
37. Holger KM, Juul J. The suffering of tinnitus in childhood and adolescence. Int J Audiol 2006; 45: 267-272.
38. Konig O, Schaette R, Kempter R, et al. Course of hearing loss and occurrence of tinnitus. Hearing Res 2006; 221: 59-64.
39. Turner CW. Hearing loss and the limits of amplification. Audiol Neurotol 2006; 11: 2-5.
40. Louie AD, Robison LL, Bogue M, et al. Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant 2000; 25: 1191-1196.
41. Moeller MP. Current state of knowledge: Psychological development in children with hearing impairment. Ear Hear 2007; 28: 729-739.